This study aimed to comparatively evaluate the anticancer and antimicrobial activities of conjugates formed from poly(maleic anhydride-co-vinyl acetate) (MAVA) and carbon quantum dots (CNDs) with o-phenylenediamine (o-PDA). o-PDA was chosen as the conjugation agent due to its status as a significant aromatic six-membered diamine, which enables specific reactions in the field of drug discovery. MAVA and CNDs, which are low-toxicity carrier systems, were prepared according to a previously developed protocol and conjugated with o-PDA to yield MAVA/o-PDA and CNDs/o-PDA. The structural characteristics of the conjugates were confirmed by ATR-FTIR and 1H-NMR analyses. The cytotoxic effects of the obtained conjugates on MG-63, A549, and MCF-7 cancer cell lines and healthy WI-38 cells, as well as their antimicrobial activities against various Gram-positive and Gram-negative bacteria, were evaluated. Additionally, ADMET properties and drug-likeness profiles were analyzed in silico to support the biological findings. While neither conjugate induced significant cytotoxicity in healthy WI-38 cells, they exhibited a stronger cytotoxic effect in cancer cells compared to o-PDA alone and the carrier systems. CNDs/o-PDA was found to be more effective than MAVA/o-PDA in MG-63, A549, and MCF-7 cells, whereas MAVA/o-PDA exhibited stronger activity in C6 cells. The conjugates also exhibited higher antimicrobial activity than their individual components, particularly against Gram-negative bacteria. In general, it has been observed that conjugation with o-PDA can enhance the biological activities of MAVA and CNDs while limiting toxicity in normal cells.
No takes yet. Share an insight, caveat, or question.
Tunç et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: